ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC)

Huang, Guang-zhao; Wu, Qing-qing; Zheng, Ze-nan; Shao, Ting-ru; Li, Fei; Lu, Xin-yan; Ye, Heng-yu; Chen, Gao-xiang; Song, Yu-xing; Zeng, Wei-sen; Ai, Yi-long*; Lv, Xiao-zhi*佛山科学技术学院; 南方医科大学
OncoTargets and Therapy2021DOI: 10.2147/OTT.S293148
13被引6阅读
引用收藏
分享

摘要

Purpose: Plenty of studies showed that the immune system was associated with cancer initiation and progression. This study aimed to explore the prognostic biomarkers from immune-related genes (IRGs) in oral squamous cell carcinoma (OSCC). @@@ Materials and Methods: RNA-seq data were downloaded from The Cancer Genome Atlas (TCGA) and IRGs and transcription factors (TFs) were extracted. Then, the co-expression network between IRGs and TFs was constructed using the "WGCNA" package in R software. Furthermore, a gene expression signature according to IRGs was constructed to predict OSCC prognosis and its accuracy was validated by survival analysis. Subsequently, correlation analyses between risk-score and immune cells level and clinical parameters were performed. Finally, immune-related biomarkers were selected and further investigated using gain-of-function assays in vitro. @@@ Results: A total of 32 normal cases and 317 OSCC cases were selected in our study. Differentially-expressed analysis indicated that there were 381 differentially-expressed IRGs and 62 TFs in OSCC. Among them, 25 TFs and 21 IRGs were enrolled in the coexpression network. Furthermore, we found that gene expression signature on the basis of 10 IRGs could predict the prognosis accurately and a high-risk score based on gene expression signature meant a high T classification, terminal clinical stage, and low immune cells level in OSCC. Finally, cathepsin G (CTSG) was identified as a potential immune-related biomarker and therapeutic target in OSCC. @@@ Conclusion: In conclusion, IRGs were directly involved in the development and progression of OSCC. Furthermore, CTSG was identified as a potential independent biomarker and might be an immunotherapeutic target in OSCC treatment.

学科与关键词

关键词
oral squamous cell carcinomaimmunebiomarkerbioinformaticsCTSG
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
OncoTargets and Therapy
发表日期
2021
卷期
第 14 卷
页码
1275-1289
DOI
10.2147/OTT.S293148
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81472536]; Science and Technology Planning Project of Guangdong Province [2017A020215181, 2014A020212440]; Project of Educational Commission of Guangdong Province of China [2018KTSCX026]; Scientific Research Planning Project of Southern Medical University [CX2018N016]; Presidential Foundation of the Nanfang Hospital [2014027, 2019Z030]

作者

  • H

    Huang, Guang-zhao (第一作者)

    southern med univ

  • W

    Wu, Qing-qing

    southern med univ

查看全部 12 位作者收起作者
  • Z

    Zheng, Ze-nan

    southern med univ

  • S

    Shao, Ting-ru

    southern med univ

  • L

    Li, Fei

    southern med univ

  • L

    Lu, Xin-yan

    southern med univ

  • Y

    Ye, Heng-yu

    southern med univ

  • C

    Chen, Gao-xiang

    southern med univ

  • S

    Song, Yu-xing

    southern med univ

  • Z

    Zeng, Wei-sen

    southern med univ

  • A

    Ai, Yi-long (通讯)

    foshan univ

  • L

    Lv, Xiao-zhi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417